ID

20308

Beschreibung

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Visit 1 (Month 0) Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Stichworte

Versionen (2)
  1. 15.02.17 15.02.17 -
  2. 20.02.17 20.02.17 -
Hochgeladen am

20. Februar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Englisch

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare  
Toast Criteria
Beschreibung

Toast Criteria

Alias
UMLS CUI-1
C1710306
For the qualifying stroke, please categories the etiologic subtype below (indicate one only)
Beschreibung

Etiologic subtype

Datentyp

integer

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0015127
Concomitant Medication
Beschreibung

Concomitant Medication

Alias
UMLS CUI-1
C2347852
Are any medications listed below currently being taken on the day of visit 1?
Beschreibung

Medication taken

Datentyp

boolean

Alias
UMLS CUI [1]
C1553892
If yes, please indicate which, if any, of the following are currently being taken:
Beschreibung

If the patient is taking any restricted (bolded) concomitant medications (see facing page), please ensure these are stopped prior to randomasation.

Datentyp

integer

Alias
UMLS CUI [1]
C1553892
ACE Inhibitors
Beschreibung

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
Are ACE Inhibitors currently being taken on the day of visit 1?
Beschreibung

ACE Inhibitors currently taken

Datentyp

boolean

Alias
UMLS CUI [1]
C0013227
Name of ACE Inhibitor and Total Daily Dose
Beschreibung

Name of ACE Inhibitor and Total Daily Dose

Datentyp

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C2360065
UMLS CUI [2,1]
C0003015
UMLS CUI [2,2]
C2348070
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Toast Criteria
C1710306 (UMLS CUI-1)
Item
For the qualifying stroke, please categories the etiologic subtype below (indicate one only)
integer
C0038454 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
Etiologic subtype
Code List
For the qualifying stroke, please categories the etiologic subtype below (indicate one only)
CL Item
Large-artery atherosclerosis (1)
CL Item
Cardioembolism (2)
CL Item
Small-artery occlusion (lacune) (3)
CL Item
Acute stroke of other determined etiology (4)
CL Item
Stroke of underdetermined etiology (5)
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Medication taken
Item
Are any medications listed below currently being taken on the day of visit 1?
boolean
C1553892 (UMLS CUI [1])
Item
If yes, please indicate which, if any, of the following are currently being taken:
integer
C1553892 (UMLS CUI [1])
If yes, please indicate which
Code List
If yes, please indicate which, if any, of the following are currently being taken:
CL Item
Dipyridamole (0)
CL Item
Aspirin (1)
CL Item
Ticlopidine (2)
CL Item
Clopidogrel (3)
CL Item
Aspirin/extended release Dipyridamole (4)
CL Item
Oral anticoagulants (5)
CL Item
Nitrates (oral or topical) (6)
CL Item
Estrogen replacement without progesterone (7)
CL Item
Estrogen replacement with progesterone (8)
CL Item
Digitalis (9)
CL Item
Statins (10)
CL Item
Fibrates (11)
CL Item
Dilitazem/Verapamil (12)
CL Item
Other calcium channel blockers (13)
CL Item
Alpha-blocker (14)
CL Item
Direct vasodilators (15)
CL Item
Angiotensin Receptor Blocker (ARB) (16)
CL Item
Peripheral sympatholytic (17)
CL Item
Central sympatholytic (18)
CL Item
Alpha-beta blocker (19)
CL Item
Beta-blocker (20)
CL Item
Loop-active diuretics (21)
CL Item
Diuretics of thiazide type (22)
CL Item
Potassium-sparing diuretics (23)
CL Item
Insulin (24)
CL Item
Oral hypoglycemic agents (25)
CL Item
Non-steroidal anti-inflammatory drugs (26)
CL Item
Specific Cox II inhibitors (27)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
Are ACE Inhibitors currently being taken on the day of visit 1?
boolean
C0013227 (UMLS CUI [1])
Name of ACE Inhibitor and Total Daily Dose
Item
Name of ACE Inhibitor and Total Daily Dose
text
C0003015 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
C0003015 (UMLS CUI [2,1])
C2348070 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video